Guidance: Clinical investigations: biological safety assessments
How to carry out the biological safety evaluation, which is required before undertaking a clinical i...
Publisher
UK
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
How to carry out the biological safety evaluation, which is required before undertaking a clinical i...
Source route
Continue on gov.uk
Leave the platform to read the original full article on the publisher site.
Source: MHRA UK
Scope: Regulatory
Related coverage
More related coverage
What's New Related to Drugs
Want to know what's new on drugs from FDA? This page provides quick links to the latest on a variety...
Generic Drug User Fee Amendments
This page features news and information for industry and stakeholders about GDUFA, its fee structure...
What’s New for Biologics
Latest news from the Center for Biologics Evaluation and Research
Perspectives : Pourquoi la pharma change de visage ?
Perspectives : Pourquoi la pharma change de visage ? Julien Gougerot lun 30/03/2026 - 14:56 Vieillis...